US Patent Issued to NANOPHAGIX on July 1 for "Drug delivery and imaging chemical conjugate, formulations and methods of use thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,619, issued on July 1, was assigned to NANOPHAGIX (Berwyn, Pa.).

"Drug delivery and imaging chemical conjugate, formulations and methods of use thereof" was invented by Steven Jay Adelman (Doylestown, Pa.), H. Donlon Skerrett (Wayne, Pa.) and William A. Kinney (Newtown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mT...